Sign in

CIK 0001401667 · Accelerated filer<br>Smaller reporting company

PUMA BIOTECHNOLOGY, INC.

Sign in to watch
Ticker
PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770683487
Phone
(424) 248-6500
Business address
10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
Former names
INNOVATIVE ACQUISITIONS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$612,494
in 2 filings, $612K under 10b5-1 plans

Net −$612,494. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cesano Alessandra −$567K Director sold 52% of stake
  2. WILSON TROY EDWARD −$46K Director sold 8% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-14 WILSON TROY EDWARD Director Sale 10b5-1 −5,000 $9.10 $46K 54,750
2026-06-12 WILSON TROY EDWARD Director Sale 10b5-1 −10,800 $7.20 $78K 59,750
2026-06-11 WILSON TROY EDWARD Director Grant or award 10b5-1 +27,000 70,550
2025-06-13 WILSON TROY EDWARD Director Sale 10b5-1 −10,800 $3.40 $37K 43,550
2025-06-11 WILSON TROY EDWARD Director Grant or award +27,000 54,350
2024-06-18 WILSON TROY EDWARD Director Grant or award +27,000 27,350
2024-06-13 WILSON TROY EDWARD Director Sale 10b5-1 −27,000 $3.33 $90K 350
2023-06-13 WILSON TROY EDWARD Director Sale 10b5-1 −27,000 $3.45 $93K 350
2023-06-13 WILSON TROY EDWARD Director Grant or award 10b5-1 +27,000 27,350

Page 1 of 1 · 9 trades